Resultado da Busca
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) are posted with the latest update date and version number. Acute Lymphoblastic Leukemia Version: 4.2023
- Guidelines Detail
Hepatobiliary Cancers Hepatocellular Carcinoma Histiocytic...
- Guidelines for Patients
NCCN Guidelines and illustrations (including algorithms) may...
- Guidelines Detail
Global. GuidelinesTreatment by Cancer TypeDetection, Prevention, and Risk ReductionSupportive CareSpecific PopulationsGuidelines for PatientsGuidelines With Evidence BlocksNCCN Framework For Resource StratificationHarmonized GuidelinesInternational Adaptations and TranslationsNCCN Mobile AppsGuidelines ProcessGuidelines Panels and ...
1 de abr. de 2021 · Overview of Staging and Treatment of Cutaneous Melanoma. Cutaneous melanomas are categorized as follows: localized disease with no evidence of regional or distant metastases (stages 0–II), regional nodal/in-transit disease (stage III), and distant metastatic disease (stage IV).
- Susan M. Swetter, John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Gene...
- 2021
1 de abr. de 2021 · Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), a ….
- Susan M. Swetter, John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Gene...
- 2021
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy.
- Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher Barker, William E. Carson, Carlo Co...
- 2019
26 de jun. de 2023 · Summarize the guidelines from the National Comprehensive Cancer Network (NCCN), Cancer Council Australia, American Association of Dermatology (AAD), and European Society of Medical Oncology (ESMO) for the diagnosis of cutaneous malignant melanoma
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020).
